Sheila DeWitt

Sheila DeWitt

Director/Board Member at ENVERIC BIOSCIENCES, INC.

Net worth: 17 912 $ as of 31/05/2026

65 year
Health Technology
Consumer Services
Commercial Services

Profile

Sheila DeWitt is the founder of Deuterx LLC, founded in 2012, holding the titles of Chairman, President & Chief Executive Officer.
Dr. DeWitt is also the founder of Diversomer Technologies, Inc...
Dr. DeWitt currently serves as Director at Riffit, Inc., Chief Operating Officer & Director at Neuromity Therapeutics, Inc., and Independent Director at Enveric Biosciences, Inc. since 2024.
Former positions include Chairman, President & Chief Executive Officer at Deuteria Pharmaceuticals, Inc. from 2010 to 2012, Vice President-Portfolio Development at ArQule, Inc., Vice President-Discovery at EPIX Pharmaceuticals, Inc. from 2005 to 2009, and Business Unit Head at Orchid Cellmark, Inc. Education includes a doctorate from Duke University conferred in 1986 and an undergraduate degree from Cornell University conferred in 1982.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/06/2026 7,788 ( 0.21% ) 17 912 $ 31/05/2026

Sheila DeWitt active positions

CompaniesPositionStart
ENVERIC BIOSCIENCES, INC. Director/Board Member 01/05/2024
Chief Executive Officer 01/01/2012
Director/Board Member -

Former positions of Sheila DeWitt

CompaniesPositionEnd
Chief Executive Officer 01/12/2012
Diversomer Technologies, Inc.
Founder -
ARQULE, INC. Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Sheila DeWitt's experience

Training of Sheila DeWitt

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

98

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Diversomer Technologies, Inc.

Health Technology

Health Technology

Health Technology

Health Services

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!